Found 930 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The REAL AF Registry is an observational, prospective, non-randomized registry designed to find out more about the outcomes for patients who receive an ablation as treatment for Paroxysmal Atrial Fibrillation (PAF) and Persistent (PsAF) Atrial Fibrillation. The registry aims to better understand real-world information for patients with this disorder. Eligible …
This phase 3 trial studies how well active surveillance help doctors to monitor subjects with low-risk germ cell tumors for recurrence after their tumor is removed. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells. The trial studies whether carboplatin or cisplatin is the …
This is a phase 1, randomized, double-blind, placebo-controlled, safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy study of oral verdiperstat (BHV-3241) in patients with semantic variant Primary Progressive Aphasia (svPPA) due to Frontotemporal Lobar Degeneration with TDP-43 pathology (FTLD-TDP).
Study CC-91633-AML-001 is a Phase 1, open-label, dose escalation and expansion, first-in-human (FIH) clinical study of CC-91633 (BMS-986397) in participants with relapsed or refractory acute myeloid leukemia (R/R AML) or in participants with relapsed or refractory higher-risk myelodysplastic syndromes (R/R HR-MDS). We would like to rely on WCG IRB as …
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas. CPI-0209 is a small molecule inhibitor of EZH2.
This natural history study will collect data to contribute to the development of future novel therapies that focus on the neuropathophysiological features that underlie ALSP and that are essential to reverse, delay, or stop progression of this debilitating disorder.
The purpose of the study is to define the safety and tolerability of ascending doses of VB119 in subjects with primary membranous nephropathy. Study drug will be administered intravenously. The Data Review Committee will review safety data and determine dosage based on available safety, PD and other clinical data. Participants …
This trial explores the efficacy of 3 doses (20 mg, 40 mg, and 80 mg) of BI 764198 with respect to their benefit to lower proteinuria, and investigates the safety, tolerability, and pharmacokinetic and pharmacodynamic profiles of BI 764198 vs placebo.
The ComboMATCH precision medicine trial will include multiple components: this non-treatment ComboMATCH Registration Trial, an informatics component for specimen and genomic data management, and multiple ComboMATCH Treatment Trials.
Prospective, multi-center, pivotal study in which data from subjects undergoing treatment with the Duett Vascular Graft System will be analyzed in comparison to historical data from the literature per Helder (2020). The study is designed to evaluate the safety and effectiveness of the Duett Vascular Graft System when functioning as …
